MedPath
HSA Approval

MUCINEX EXTENDED RELEASE TABLETS 1200MG

SIN14659P

MUCINEX EXTENDED RELEASE TABLETS 1200MG

MUCINEX EXTENDED RELEASE TABLETS 1200MG

November 7, 2014

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRECKITT BENCKISER (SINGAPORE) PTE LTD
Licence HolderRECKITT BENCKISER (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, MULTILAYER, EXTENDED RELEASE

ORAL

Medical Information

R05CA03

guaifenesin

Manufacturer Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

Reckitt Benckiser Healthcare International Limited

Active Ingredients

Guaifenesin

1200mg

Guaifenesin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MUCINEX EXTENDED RELEASE TABLETS 1200MG - HSA Approval | MedPath